2026-07-28T05:43:34Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1073172025-03-18T15:02:12Zcom_20.500.14352_14col_20.500.14352_15

00925njm 22002777a 4500 dc Huntley, Dixie author Giménez, Estela author Pascual, María Jesús author Vázquez, Lourdes author Amat, Paula author Remigia, María José author Hernández Martín, Marta María author Hernández Boluda, Juan Carlos author Gago, Beatriz author Piñana, José Luis author García, Magdalena author Pérez, Ariadna author Alberola, Juan author Gozalbo Rovira, Roberto author Albert, Eliseo author Solano, Carlos author Navarro, David author 2020-05-23 Cytomegalovirus (CMV) DNAemia remains a clinically relevant problem following allogeneic stem cell transplantation (allo-HSCT). Currently, enumeration of IFN-γ- producing CMV-specific T cells provides helpful yet improvable data for patient stratification for risk of primary or recurrent CMV DNAemia and for predicting clinically refractory episodes of CMV DNAemia. Huntley, D., Giménez, E., Pascual, M.J. et al. Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant 55, 1493–1496 (2020). https://doi.org/10.1038/s41409-020-0950-1 0268-3369 1476-5365 10.1038/s41409-020-0950-1 https://hdl.handle.net/20.500.14352/107317 https://doi.org/10.1038/s41409-020-0950-1 https://www.nature.com/bmt/ Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide